Link
New Brunswick Influenza Activity Summary Report: 2017-2018 season
Organization: Government of New BrunswickPublished: 2018
"Highlights of the 2017-2018 Influenza season:
- This season, influenza activity peaked between week 8 and 10 ( February 18 to March 10, 2018) in New Brunswick. Nationally, the peak of activity, mainly driven by the Western Provinces, was observed at week 6 (February 4 to February 10, 2018).
- In New Brunswick, the activity in the current season started very early compared to previous years: influenza activity was ongoing since week 40 (early October) which is atypical for New Brunswick where sustained activity is usually observed starting week 51 or 52 (end of December).
- The number of influenza tests submitted had increased by more than 4400 tests compared to the previous season and the overall positivity rate was higher (26% versus 20% in 2016-2017).
- Up to June 23 2018, 2719 laboratory confirmed influenza cases were reported: 1408 were influenza A (52% of all positive) and 1296 were influenza B (48% of all positive)..." - New Brunswick Influenza Activity Summary Report: 2017-2018 season
Resource Group:
Background Knowledge
Product Type: Report
Vaccine Preventable Disease Surveillance
Provincial and Territorial Surveillance
Communicable Diseases
Vaccine Preventable Diseases
Influenza
Product Type: Report
Category:
Monitoring and Surveillance,Vaccine Preventable Disease Surveillance,Provincial and Territorial Surveillance,Communicable Diseases,Vaccine Preventable Diseases,Influenza Monitoring and SurveillanceVaccine Preventable Disease Surveillance
Provincial and Territorial Surveillance
Communicable Diseases
Vaccine Preventable Diseases
Influenza
Audience:
Health Care Professional
Population: Adults
Children (All)
Seniors
Region: New Brunswick (NB)
Population: Adults
Children (All)
Seniors
Region: New Brunswick (NB)
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.